The present invention provides a compound having TrkA inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention relates to a compound represented by Formula (I): wherein =X is =O or the like, R 5 and R 5A are hydrogen atoms or the like, -A- is -NR 1 - or the like, B is substituted or unsubstituted aromatic carbocyclyl or the like, R 1 is substituted or unsubstituted alkyl or the like, R 2 is a hydrogen atom or the like, -W-is -CH 2 - or the like, -W A - is -CH 2 - or the like, R 13 is substituted or unsubstituted aromatic carbocyclyl or the like, R 14 is substituted or unsubstituted aromatic heterocyclyl or the like, R 15 is substituted or unsubstituted alkyl or the like, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same.
